Teclistamab T-cell therapy shows promise in patients with drug-resistant autoimmune disease

Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune diseases.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup